CSPC Pharmaceutical Group Ltd banner
C

CSPC Pharmaceutical Group Ltd
OTC:CHJTF

Watchlist Manager
CSPC Pharmaceutical Group Ltd
OTC:CHJTF
Watchlist
Price: 1.05 USD Market Closed
Market Cap: $12.4B

Wall St Price Targets

CHJTF Price Targets Summary
CSPC Pharmaceutical Group Ltd

Wall Street analysts forecast CHJTF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHJTF is 1.72 USD with a low forecast of 0.99 USD and a high forecast of 3.01 USD.

Lowest Forecast
Price Target
0.99 USD
6% Downside
Average Forecast
Price Target
1.72 USD
64% Upside
Highest Forecast
Price Target
3.01 USD
187% Upside
CSPC Pharmaceutical Group Ltd Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 8%.

Gross Profit
Forecast

21% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
21% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for CSPC Pharmaceutical Group Ltd

Operating Income
Forecast

21% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
21% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 14%.

Pre-Tax Income
Forecast

23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for CSPC Pharmaceutical Group Ltd

Net Income
Forecast

24% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
24% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHJTF's stock price target?
Price Target
1.72 USD

According to Wall Street analysts, the average 1-year price target for CHJTF is 1.72 USD with a low forecast of 0.99 USD and a high forecast of 3.01 USD.

What is the Revenue forecast for CSPC Pharmaceutical Group Ltd?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 8%.

What is the Operating Income forecast for CSPC Pharmaceutical Group Ltd?
Projected CAGR
14%

Over the last 14 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 14%.

What is the Net Income forecast for CSPC Pharmaceutical Group Ltd?
Projected CAGR
18%

Over the last 14 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett